Search research articles
Contact Us
Filters
Showing results (1-10 of 15) with videos related to
Page
of 2
Sort By:
Lakartidningen
|
November 8, 2007
[Health economics evaluations are of great significance for Pharmaceutical Benefit Board's decisions]
Ulf Persson, Joakim Ramsberg
The New England Journal of Medicine
|
April 21, 2016
Challenges for Sharing Data from Embedded Research
Richard Platt, Joakim Ramsberg
Health Economics
|
September 25, 2007
On survival consumption costs: a reply to Nyman
Douglas Lundin, Joakim Ramsberg
Learning Health Systems
|
June 28, 2019
Opportunities and barriers for pragmatic embedded trials: Triumphs and tribulations
Joakim Ramsberg, Richard Platt
Plos One
|
August 10, 2012
Effectiveness and cost-effectiveness of antidepressants in primary care: a multiple treatment comparison meta-analysis and cost-effectiveness model
Joakim Ramsberg, Christian Asseburg, Martin Henriksson
Lakartidningen
|
February 24, 2006
[Why patent-protected drugs' cost efficiency should be compared with generic preparations]
Fredrik Berggren, Douglas Lundin, Joakim Ramsberg
BMJ Open
|
January 7, 2012
A cost-effectiveness analysis of an in-hospital clinical pharmacist service
Susanna M Wallerstedt, Lina Bladh, Joakim Ramsberg
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care
|
September 29, 2004
Examining the quality of health economic analyses submitted to the Pharmaceutical Benefits Board in Sweden. The first year
Joakim Ramsberg, Stefan Odeberg, Andreas Engström, et al.
Health Policy (Amsterdam, Netherlands)
|
March 17, 2015
Patient perspectives on centralisation of low volume, highly specialised procedures in Sweden
Ida Svederud, Martin Virhage, Emma Medin, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
September 20, 2014
Analyzing overall survival in randomized controlled trials with crossover and implications for economic evaluation
Linus Jönsson, Rickard Sandin, Mattias Ekman, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 15) with videos related to
Sort By:
Page
of 2
Lakartidningen
|
November 8, 2007
[Health economics evaluations are of great significance for Pharmaceutical Benefit Board's decisions]
Ulf Persson, Joakim Ramsberg
The New England Journal of Medicine
|
April 21, 2016
Challenges for Sharing Data from Embedded Research
Richard Platt, Joakim Ramsberg
Health Economics
|
September 25, 2007
On survival consumption costs: a reply to Nyman
Douglas Lundin, Joakim Ramsberg
Learning Health Systems
|
June 28, 2019
Opportunities and barriers for pragmatic embedded trials: Triumphs and tribulations
Joakim Ramsberg, Richard Platt
Plos One
|
August 10, 2012
Effectiveness and cost-effectiveness of antidepressants in primary care: a multiple treatment comparison meta-analysis and cost-effectiveness model
Joakim Ramsberg, Christian Asseburg, Martin Henriksson
Lakartidningen
|
February 24, 2006
[Why patent-protected drugs' cost efficiency should be compared with generic preparations]
Fredrik Berggren, Douglas Lundin, Joakim Ramsberg
BMJ Open
|
January 7, 2012
A cost-effectiveness analysis of an in-hospital clinical pharmacist service
Susanna M Wallerstedt, Lina Bladh, Joakim Ramsberg
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care
|
September 29, 2004
Examining the quality of health economic analyses submitted to the Pharmaceutical Benefits Board in Sweden. The first year
Joakim Ramsberg, Stefan Odeberg, Andreas Engström, et al.
Health Policy (Amsterdam, Netherlands)
|
March 17, 2015
Patient perspectives on centralisation of low volume, highly specialised procedures in Sweden
Ida Svederud, Martin Virhage, Emma Medin, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
September 20, 2014
Analyzing overall survival in randomized controlled trials with crossover and implications for economic evaluation
Linus Jönsson, Rickard Sandin, Mattias Ekman, et al.
Page
of 2